Repatha (evolocumab) - Amgen, Astellas
https://cattendee.abstractsonline.com/meeting/21541/presentation/8186
 
Jan Hein Cornel, Radboudumc, Nijmegen, Netherlands; Robert Giugliano, TIMI Study Group, Brigham & Women's Hosp, Boston, MA; Gaetano M De Ferrari, IRCCS Policlinico San Matteo, Pavia, Italy; Gaetano Maria De Ferrari, Univ of Torino, Torino, Italy; Lawrence A Leiter, Univ of Toronto, Toronto, ON, Canada; Jose C Nicolau, Univ. of Sao Paulo Medical Sch, Sao Paulo, Brazil; ajay bhatia, Amgen Inc, Thousand Oaks, CA; Jeong-Gun Park, Julia Kuder, Sabina Murphy, TIMI Study Group, Brigham & Women's Hosp, Boston, MA; Lyrica Liu, Huei Wang, Amgen Inc, Thousand Oaks, CA; Min-Ji Charng, Shin Kong Wu Ho-Su Memorial Hosp, Taipei, Taiwan; Jorge M Ferreira, Hosp de Santa Cruz, Carnaxide, Portugal; Ioanna Gouni-Berthold, Univ Clinic of Cologne, Bonn, Germany; Henrik Jensen, Aarhus Univ Hosp, Aarhus, Denmark; Robert Gabor Kiss, Medical Ctr Hungarian Defence Fo, Budapest, Hungary; Johanna Kuusisto, Kuopio Univ Hosp, Kuopio, Finland; Jacob Odenstedt, Dept of Cardiology, Gothenburg, Sweden; Oleksandr Parkhomenko, Natl Scientific Ctr, Kyiv, Ukraine; Naveed Sattar, Univ of Glasgow, Glasgow, United Kingdom; KONSTANTINOS TSIOUFIS, Natl & Kapodistrian Univ of Athens Medical Sch, Athens, Greece; Marc S Sabatine, Erin Bohula, TIMI Study Group, Brigham & Women's Hosp, Boston, MA
 
Sep 5, 2026
 
Prev Next